Early Intervention With Biologics for Asthma Remission: Promising or Premature?
Santi Nolasco, Jaime Bernaola, Parameswaran Nair · 2026
Read Early Intervention With Biologics for Asthma Remission: Promising or Premature? by Santi Nolasco, Jaime Bernaola, Parameswaran Nair (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13432523.txt.
Description
Santi Nolasco, Jaime Bernaola, and Parameswaran Nair asked a pointed question in 2026. Could starting targeted biologic drugs early in asthma lift the odds of full calm, or does the hope run ahead of proof? Such drugs aim at key sparks of one asthma type. Calm, by agreed marks, blends quiet symptoms, steady lung tests, and no flare-ups or daily steroid pills.
Across drug kinds, calm stalls at a fifth to two fifths of patients. Wider tests to pick the right drug may push the share higher. Long disease runs cut the odds of calm, since harm and side faults pile up over years. The authors press on weak spots in the early-start case. Calm on the surface may not mean the deep disease has cleared. Mild asthma may never march toward severe forms at all.
Catalog record
| CREATOR | Santi Nolasco, Jaime Bernaola, Parameswaran Nair |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 11400 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |